Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib

Eli Lilly’s master protocol is designed to assess the long-term safety and efficacy of pirtobrutinib in participants from prior originator studies. This framework, using individual study-specific appendices, enables former trial patients to continue treatment or follow-up visits, providing critical extended data for pirtobrutinib’s safety profile.